Survival benefit of neoadjuvant therapy in patients with non-metastatic pancreatic ductal adenocarcinoma: A propensity matching and intention-to-treat analysis.

Motokazu SugimotoNaoki TakahashiMichael B FarnellThomas C SmyrkMark J TrutyDavid M NagorneyRory L SmootSuresh T ChariRickey E CarterMichael L Kendrick

Published in: Journal of surgical oncology (2019)

The strategy of neoadjuvant therapy before surgical resection appears to offer pathologic effect and survival benefit for the patients presenting with non-metastatic PDAC.

Keyphrases

locally advanced
rectal cancer
squamous cell carcinoma
small cell lung cancer
lymph node
neoadjuvant chemotherapy
free survival
radiation therapy
mesenchymal stem cells